Adaptive Biotechnologies Corporation Common Stock (1HM)
XDUS
Closed
Oct 14, 2026
Day's Range
22.2352 wk Range
10.53Overview - 1HM - Adaptive Biotechnologies Corporation Common Stock
Key Statistics
Valuation
Enterprise Value
8.65M
P/E (Trailing)
‪-64.17‬
PEG Ratio
‪-1.36‬
Price / Book
‪26.55‬
EV / EBITDA
‪-0.28‬
Profitability
Gross Margin
‪71.81%‬
Profit Margin
‪74.23%‬
Operating Margin
‪-17.21%‬
Return on Assets
‪-11.60%‬
Return on Equity
‪-26.44%‬
Ownership
Shares Outstanding
159.05M
Price stats
50-Day Avg
‪21.64‬
200-Day Avg
‪15.79‬
Peers - 1HM - Adaptive Biotechnologies Corporation Common Stock
Peer Comparison
Compared with companies in Diagnostics & Research listed on XDUS.
- 1HMXDUSAdaptive Biotechnologies Corporation Common Stock+52.26%52-week change-64.18P/E (Trailing)‪74.23%‬Profit Margin
- NL0XDUSGRAIL, Inc.+53.52%52-week change-10.50P/E (Trailing)‪-236.94%‬Profit Margin
- 0MEXDUSTwist Bioscience Corporation+80.08%52-week change-108.42P/E (Trailing)‪50.72%‬Profit Margin
- 1K9XDUSCareDx, Inc.+77.16%52-week change-137.50P/E (Trailing)‪67.55%‬Profit Margin
- ILUXDUSIllumina, Inc.+65.36%52-week change44.52P/E (Trailing)‪66.08%‬Profit Margin
- 5GHXDUSGuardant Health Inc.+64.22%52-week change-45.10P/E (Trailing)‪64.46%‬Profit Margin
- 04XXDUSPersonalis Inc.+51.53%52-week change-15.62P/E (Trailing)‪22.65%‬Profit Margin
Profile Summary - 1HM - Adaptive Biotechnologies Corporation Common Stock
About
Adaptive Biotechnologies Corporation Common Stock represents the equity of Adaptive Biotechnologies Corporation, a commercial-stage biotechnology company focused on immune medicine. The company develops products and services that use immunosequencing, proprietary chemistry, computational biology, and machine learning…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
